Commentary: Antioxidants for cancer: New tricks for an old dog?

Nima Sharifi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Traditionally, the main focus of the importance of reactive oxygen species (ROS) in oncology is that these species induce DNA damage, leading to a predisposition to cancer. However, it has recently been shown that ROS may have an alternative activity, by modulating tumor cell signaling. Moreover, tumor cell signaling mediated by ROS is readily reversible upon treatment with antioxidants. This emerging evidence on the molecular effects of antioxidants on tumor cells, along with the evidence that the route of administration of antioxidants in earlier clinical trials for cancer could not achieve pharmacologically effective levels, suggests that antioxidants may serve as bona fide signal transduction modifiers for cancer. A re-examination of the current evidence and further study is clearly warranted.

Original languageEnglish (US)
Pages (from-to)213-215
Number of pages3
JournalOncologist
Volume14
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Antioxidants
Dogs
Reactive Oxygen Species
Neoplasms
DNA Damage
Signal Transduction
Clinical Trials

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Commentary : Antioxidants for cancer: New tricks for an old dog? / Sharifi, Nima.

In: Oncologist, Vol. 14, No. 3, 03.2009, p. 213-215.

Research output: Contribution to journalArticle

Sharifi, Nima. / Commentary : Antioxidants for cancer: New tricks for an old dog?. In: Oncologist. 2009 ; Vol. 14, No. 3. pp. 213-215.
@article{568d3f6efedf43c1ac179ff994ab5069,
title = "Commentary: Antioxidants for cancer: New tricks for an old dog?",
abstract = "Traditionally, the main focus of the importance of reactive oxygen species (ROS) in oncology is that these species induce DNA damage, leading to a predisposition to cancer. However, it has recently been shown that ROS may have an alternative activity, by modulating tumor cell signaling. Moreover, tumor cell signaling mediated by ROS is readily reversible upon treatment with antioxidants. This emerging evidence on the molecular effects of antioxidants on tumor cells, along with the evidence that the route of administration of antioxidants in earlier clinical trials for cancer could not achieve pharmacologically effective levels, suggests that antioxidants may serve as bona fide signal transduction modifiers for cancer. A re-examination of the current evidence and further study is clearly warranted.",
author = "Nima Sharifi",
year = "2009",
month = "3",
doi = "10.1634/theoncologist.2008-0219",
language = "English (US)",
volume = "14",
pages = "213--215",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "3",

}

TY - JOUR

T1 - Commentary

T2 - Antioxidants for cancer: New tricks for an old dog?

AU - Sharifi, Nima

PY - 2009/3

Y1 - 2009/3

N2 - Traditionally, the main focus of the importance of reactive oxygen species (ROS) in oncology is that these species induce DNA damage, leading to a predisposition to cancer. However, it has recently been shown that ROS may have an alternative activity, by modulating tumor cell signaling. Moreover, tumor cell signaling mediated by ROS is readily reversible upon treatment with antioxidants. This emerging evidence on the molecular effects of antioxidants on tumor cells, along with the evidence that the route of administration of antioxidants in earlier clinical trials for cancer could not achieve pharmacologically effective levels, suggests that antioxidants may serve as bona fide signal transduction modifiers for cancer. A re-examination of the current evidence and further study is clearly warranted.

AB - Traditionally, the main focus of the importance of reactive oxygen species (ROS) in oncology is that these species induce DNA damage, leading to a predisposition to cancer. However, it has recently been shown that ROS may have an alternative activity, by modulating tumor cell signaling. Moreover, tumor cell signaling mediated by ROS is readily reversible upon treatment with antioxidants. This emerging evidence on the molecular effects of antioxidants on tumor cells, along with the evidence that the route of administration of antioxidants in earlier clinical trials for cancer could not achieve pharmacologically effective levels, suggests that antioxidants may serve as bona fide signal transduction modifiers for cancer. A re-examination of the current evidence and further study is clearly warranted.

UR - http://www.scopus.com/inward/record.url?scp=63849093678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63849093678&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2008-0219

DO - 10.1634/theoncologist.2008-0219

M3 - Article

C2 - 19264825

AN - SCOPUS:63849093678

VL - 14

SP - 213

EP - 215

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 3

ER -